Ignite Creation Date:
2024-05-06 @ 3:05 AM
Last Modification Date:
2024-10-26 @ 11:28 AM
Study NCT ID:
NCT02200822
Status:
COMPLETED
Last Update Posted:
2019-08-01
First Post:
2014-07-24
Brief Title:
Systematic Withdrawal of Neurohumoral Blocker Therapy in Optimally Responding CRT Patients
Sponsor:
Hasselt University
Organization:
Hasselt University
Study Overview
Official Title:
Systematic Withdrawal of Neurohumoral Blocker Therapy in Optimally Responding Patients to Cardiac Resynchronization Therapy the STOP-CRT Trial
Status:
COMPLETED
Status Verified Date:
2019-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
STOP-CRT
Brief Summary:
The primary objective of this study is to demonstrate that in patients with recuperatednormalized left ventricular function defined as an ejection fraction EF 50 after implantation of cardiac resynchronization therapy device treatment is sufficient and neurohumoral blocker therapy can safely be withdrawn
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None